Top CAR-T Therapy Stock by Market Performance | Edgen

Top CAR-T Therapy Stock by Market Performance | Edgen

Investment in immune cell therapy for cancer treatment, benefiting from CAR-T technology development and commercialization.

24H Performance

3.36%

Beta0.56



Stock	Price	Chg %	Price Change	YTD Chg%	Volume	Market Cap	Rating	Last 7 days

Post-market | Last updated at Jun 26, 2026 17:15:49